PI3K-p110α mediates resistance to HER2-targeted therapy in HER2+, PTEN-deficient breast cancers - Concepedia

Concepedia

Publication | Open Access

PI3K-p110α mediates resistance to HER2-targeted therapy in HER2+, PTEN-deficient breast cancers

DOI Full Paper Access

42

Citations

23

References

2015

Year

Qīng Wáng, P Liu, Jennifer M. Spangle, Thanh Von, Thomas M. Roberts, Nancy U. Lin, Ian E. Krop, Eric P. Winer, Jean J. Zhao

Tumor BiologyBreast OncologyHer2-targeted TherapyMedicineCancer Cell BiologyPten-deficient Breast CancersBreast CancerCell BiologyTumor SuppressorCancer GeneticsCancer BiologyRadiation OncologyPi3k-p110α Mediates ResistanceCancer Research

References

	Year	Citations

Page 1

Page 1